SPOTLIGHT -
FDA warns opioid repackers
FDA warns opioid repackers for "significant violations."
FDA fast tracks blockbuster diabetes drug for heart failure
FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
Are certain anticholinergic meds linked to dementia risk?
The validity of a new large study linking anticholinergic drugs to the risk of dementia has stirred up controversy.
Cybersecurity glitch wreaks havoc on insulin pumps
FDA recalls insulin pumps due to cybersecurity miscommunication.
Effects of female libido drug unknown, advocacy group warns
A women’s health organization is concerned about the safety and effectiveness of bremelanotide (Vyleesi) after FDA approved it to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
Top 4 drugs in the pipeline
A new report from OptumRx reveals the top 4 drugs in development for the second quarter of 2019.
First IBS pain-relief device hits market
The first FDA-approved device to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.
Top 6 Cancer Drug Trends
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
FDA okays cluster headache drug
FDA cleared the first-and-only calcitonin gene-related peptide (CGRP) antibody for cluster headaches.
Self-injectable respiratory medication opens doors for patients with severe asthma
The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.
FDA clears novel breast cancer drug
FDA cleared alpelisib (Piqray), the first PI3K inhibitor to treat breast cancer, to be used in combination with fulvestrant (Faslodex).
Revolutionary smartphone device could offer migraine sufferers hope
FDA granted market authorization for a non-invasive, smartphone device that offers respite from migraines.
Express Scripts to launch first digital health formulary
Express Scripts, a Cigna company, plans to launch the industry's first stand-alone digital health formulary.
Top 3 new drug approvals
FDA approved some important new therapies, including the first anticoagulant for children, an injectable for diabetic retinopathy, and a treatment for renal cell carcinoma.
US accuses generic drug makers of price collusion
Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit.
Drug prices in ads run risk of confusing patients
A new government rule requiring pharma makers to disclose drug prices in television ads will likely create more confusion for consumers, analysts and organizations said.
How FDA’s insomnia drug warning could impact prescribing
Stronger warnings on popular insomnia medications could have an impact on prescribing, some experts say.
New RA biosimilar impact hinges on patent lawsuit
While FDA approved the second biosimilar drug to Enbrel, the success of the medication hinges on a pending lawsuit.
Electronic prescriptions for opioids rise, despite CDC concerns about misprescribing
CDC commentary claims patients taken off opiods too soon.
Top 6 drug research trends
A new report determines the trends fueling drug research and development over the past 10 years-and into the future.
Generic naloxone nasal spray gets green light from FDA
FDA clears first non-drug option to treat ADHD in children
FDA cleared the first medical device to treat attention deficit hyperactivity disorder (ADHD) in kids.
PBM rebate solutions flawed, study says
A Commonwealth Fund study has revealing findings about PBMs’ use of rebates and impact on drug prices.
Pharm maker, PBMs lower insulin prices
Breast cancer drug now treats men
Metastatic breast cancer drug expands treatment to men.
FDA clears first 2-drug HIV-1 regimen
FDA cleared Dovato (ViiV Healthcare), the first 2-drug regimen to treat HIV-1 in adults with no antiretroviral treatment history.
Lack of insulin competition high priority for FDA
FDA fast-tracks biosimiliar insulin products to elevate competition.
New oral drugs treat MS
FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.
New postpartum drug comes at a high price
Postpartum drug is a game changer, but can women afford it?
FDA announces 3 big drug recalls
Several companies are recalling products due to contamination from substances such as carcinogens and glass-here’s what you should know.